[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356767-105":3,"doc-detail-356767-en":81,"detail-sidebar-cat-0-en-105":107},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","endogenous-neoantigen-specific-antibodies-mediate-antitumor-responses-and-determine-vaccine-efficacy","Endogenous neoantigen-specific antibodies mediate antitumor responses and determine vaccine efficacy","","The study addresses uncertainty about how B cells and endogenous humoral immunity shape antitumor responses, and whether antigen-specific features control the protective or harmful nature of tumor-elicited antibodies. A pan-cancer TCGA analysis links intratumoral IgG to heterogeneous clinical outcomes. In vivo experiments show membrane-localized neoantigens trigger class-switched IgG, activate myeloid cells, and suppress tumors independently of CD8 T cells. Antibody effects require CD4 help, antigen-specific IgG, and Fc receptor engagement. Modulating CXCL13 or IL-21 boosts tumor control, and antigen localization also governs vaccine efficacy, including for Trop2 T256R.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/endogenous-neoantigen-specific-antibodies-mediate-antitumor-responses-and-determine-vaccine-efficacy/356767/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/endogenous-neoantigen-specific-antibodies-mediate-antitumor-responses-and-determine-vaccine-efficacy/356767.png","ImageObject",300,407,{"name":42,"@type":43},"Aditya","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the research focus on regarding B cells and antitumor immunity?","Question",{"text":63,"@type":64},"It evaluates why B cells show inconsistent effects across cancers and whether endogenous tumor-elicited antibodies can be protective or deleterious. It also tests whether specific antigenic features determine humoral response efficacy against cancer.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the study assess the clinical relevance of intratumoral IgG?",{"text":68,"@type":64},"It performed a pan-cancer analysis using TCGA to examine associations between intratumoral IgG and clinical outcomes, revealing heterogeneous prognostic impacts.",{"name":70,"@type":61,"acceptedAnswer":71},"Why does antigen localization affect vaccine efficacy in this work?",{"text":72,"@type":64},"Membrane-localized neoantigens promote potent class-switched IgG responses and tumor suppression, whereas impaired membrane localization reduces antibody binding and fails to elicit comparable vaccine-induced tumor control, as shown with Trop2 T256R.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356767,1790508290,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":86,"file_id":87,"file_url":88,"file_type":89,"file_size":90,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":91,"language":92,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":93,"faqs":94,"seo_title":95,"seo_description":12,"update_tm":96,"read_time":97,"preview_page_count":26,"preview_urls":98},962085564549,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Open access  \nTo cite: Sodhi SS, Wang JS, Severson DT, et al. Endogenous neoantigen-specific antibodies mediate antitumor responsesand determine vaccine efficacy. Journal for ImmunoTherapy of Cancer 2026;14:e014671 . doi:10.1136/jitc-2025-014671  \n► Additional supplemental material is published online only. To view, please visit the journal online ([https://doi.org/10.1136/](https://doi.org/10.1136/)[ ](https://doi.org/10.1136/)[jitc-2025-014671](jitc-2025-014671)) .  \nAccepted 07 April 2026  \n© Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.  \n1Duke University School of Medicine, Duke University, Durham, North Carolina, USA 2Department of Surgery, Duke University, Durham, North Carolina, USA  \n3Department of Pathology, Duke University, Durham, North Carolina, USA  \n4Department of Integrative Immunobiology, Duke University, Durham, North Carolina, USA  \nCorrespondence to  \nDr Zachary Conrad Hartman; [zachary.hartman@duke.edu](zachary.hartman@duke.edu)  \nOriginal research  \nEndogenous neoantigen-specific antibodies mediate antitumor responsesand determine vaccine efficacy  \nSirajbir S Sodhi,1 John S Wang,1 David T Severson  ,2 Joey V Ragusa,3 Nicole Moon,2 Timothy Trotter,2 Li-Chung Tsao,2 Herbert Kim Lyerly  ,2,4 Zachary Conrad Hartman  2,4  \nABSTRACT  \nBackground The contribution of B cells to antitumor immunity remains controversial, with studies reporting varied effects across cancer types. Even less is known about the role of the endogenous humoral response, including when tumor-elicited antibodies are protective, when they are deleterious, and how they might be modulated to influence antitumor immunity. Critically, it remains unclear whether specific antigenic features govern the efficacy of humoral immune responses against cancer. We aim to define the conditions under which endogenous antibodies mediate antitumor immunity and to leverage these principles to improve neoantigen-directed immunotherapies, including cancer vaccines.  \nMethods We performed a pan-cancer analysis of The Cancer Genome Atlas (TCGA) to assess associations between intratumoral IgG and clinical outcomes. Using syngeneic mouse tumor models expressing membrane or cytoplasmic neoantigens, we examined how antigen localization influences endogenous antibody responses. We evaluated strategies to enhance humoral immunity via cytokine and chemokine modulation and assessed antibody responses in the context of cancer vaccination. Results Our pan-cancer TCGA analysis revealed marked heterogeneity in the prognostic impact of intratumoral IgG. In vivo, expression of membrane-localized, but not cytoplasmic, neoantigens drove potent class-switched IgG responses, activated myeloid cells, and restricted tumor growth independently of CD8 T cells. Notably, membrane-restricted antigen expression was sufficient to convert tumor types such as colorectal cancer, where IgG correlates with poor prognosis, into settings in which antibodies mediate tumor suppression. These effects required CD4 T-cell help, antigen-specific IgG, and Fc receptor engagement. Enhancing B-cell recruitment (CX-C motif chemokine ligand 13) or B-cell help (interleukin (IL)-21) further amplified antibody-mediated tumor control, with co-expression providing the strongest benefit.  \nFinally, we establish that antigen localization dictates vaccine efficacy: the point-mutated trophoblast cellsurface antigen 2 (Trop2) T256R, which exhibits impaired membrane localization and reduced antibody binding relative to wild-type Trop2, failed to elicit comparable vaccine-induced tumor control.  \nConclusions These findings identify antigen subcellular localization as a key regulator of endogenous antibodymediated antitumor immunity and cancer vaccine efficacy,  \n\n| WHAT IS ALREADY KNOWN ON THIS TOPIC |\n| --- |\n| ⇒ B cells have been implicated in both tumor control and immune suppression, but their precise role in antitum","cbCaiv38hVhqDutG","https://ap.wps.com/l/cbCaiv38hVhqDutG","pdf",9445232,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# What is already known on this topic\n# What this study adds\n# How this study might affect research, practice or policy","[{\"question\":\"What problem does the research focus on regarding B cells and antitumor immunity?\",\"answer\":\"It evaluates why B cells show inconsistent effects across cancers and whether endogenous tumor-elicited antibodies can be protective or deleterious. It also tests whether specific antigenic features determine humoral response efficacy against cancer.\"},{\"question\":\"How did the study assess the clinical relevance of intratumoral IgG?\",\"answer\":\"It performed a pan-cancer analysis using TCGA to examine associations between intratumoral IgG and clinical outcomes, revealing heterogeneous prognostic impacts.\"},{\"question\":\"Why does antigen localization affect vaccine efficacy in this work?\",\"answer\":\"Membrane-localized neoantigens promote potent class-switched IgG responses and tumor suppression, whereas impaired membrane localization reduces antibody binding and fails to elicit comparable vaccine-induced tumor control, as shown with Trop2 T256R.\"}]","Endogenous neoantigen-specific antibodies mediate antitumor responses and determine vaccine efficacy | PDF",1790127186,40,[99,103],{"page_no":22,"url":100,"width":101,"height":102},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/d7da72dbd262b91fcc1d4ecf98b723bd.webp",983,1310,{"page_no":26,"url":104,"width":105,"height":106},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/f6ba1824b13ef6c0b2ab8e5048a17e3c.webp",982,1309,{"code":4,"msg":82,"data":108},[109,113,117,121,126,131,135,138,143,146,150],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":110,"show_sort_weight":111,"slug":112},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":114,"show_sort_weight":115,"slug":116},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":118,"show_sort_weight":119,"slug":120},"Exam",70,"exam",{"id":122,"doc_module":4,"doc_module_name":25,"category_name":123,"show_sort_weight":124,"slug":125},5,"Comic",60,"comic",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":129,"slug":130},6,"Technology",50,"technology",{"id":132,"doc_module":4,"doc_module_name":25,"category_name":133,"show_sort_weight":97,"slug":134},7,"Healthcare","healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":136,"slug":137},30,"research-report",{"id":139,"doc_module":4,"doc_module_name":25,"category_name":140,"show_sort_weight":141,"slug":142},9,"Religion & Spirituality",20,"religion-spirituality",{"id":141,"doc_module":4,"doc_module_name":25,"category_name":144,"show_sort_weight":141,"slug":145},"World Cup","world-cup",{"id":147,"doc_module":4,"doc_module_name":25,"category_name":148,"show_sort_weight":147,"slug":149},10,"Lifestyle","lifestyle",{"id":151,"doc_module":4,"doc_module_name":25,"category_name":152,"show_sort_weight":122,"slug":153},19,"General","general"]